103 related articles for article (PubMed ID: 11211780)
1. [In vitro antimycobacterial activities of a new quinolone, balofloxacin].
Kawahara S; Tada A; Nagare H
Kekkaku; 2001 Jan; 76(1):29-31. PubMed ID: 11211780
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antimycobacterial activity of a new quinolone, NM394].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of in vitro antimicrobial activities of ofloxacin, levofloxacin, ciprofloxacin, and sparfloxacin against various mycobacteria].
Kawahara S; Tada A; Nagare H
Kekkaku; 2001 Apr; 76(4):357-62. PubMed ID: 11398326
[TBL] [Abstract][Full Text] [Related]
5. [Antimycobacterial activity of a newly synthesized fluoroquinolone, Y-26611].
Tomioka H; Sato K; Saito H; Ikeda Y
Kekkaku; 1992 Jul; 67(7):515-20. PubMed ID: 1331603
[TBL] [Abstract][Full Text] [Related]
6. [Antimycobacterial activities of a new quinolone, sparfloxacin].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antimicrobial activity of a new quinolone, levofloxacin, against atypical mycobacteria].
Oya S; Takemoto A; Hosaka K; Kudou Y; Arakawa M
Kekkaku; 1995 Nov; 70(11):615-9. PubMed ID: 8656585
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial activity of new quinolones against Mycobacterium avium and Mycobacterium intracellulare determined by the dilution methods using 7H11 agar and Ogawa egg media].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 May; 68(5):367-70. PubMed ID: 8331881
[TBL] [Abstract][Full Text] [Related]
9. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).
Saito H; Sato K; Tomioka H; Dekio S
Tuber Lung Dis; 1995 Oct; 76(5):377-80. PubMed ID: 7495996
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic potential of sparfloxacin for preventing mycobacterial infections].
Kawahara S; Tada A; Takeuchi M; Kamisaka K; Okada C; Mishima Y; Soda R; Takahashi K; Kibata M; Nagare H
Kekkaku; 1994 May; 69(5):351-6. PubMed ID: 8007520
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.
Saito H; Tomioka H; Sato K; Dekio S
Antimicrob Agents Chemother; 1994 Dec; 38(12):2877-82. PubMed ID: 7695276
[TBL] [Abstract][Full Text] [Related]
12. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin.
Tomioka H; Saito H; Sato K
Antimicrob Agents Chemother; 1993 Jun; 37(6):1259-63. PubMed ID: 8392307
[TBL] [Abstract][Full Text] [Related]
13. [In vitro determination of the sensitivity of mycobacteria to fluoroquinolones].
Dailloux M; Petitpain N; Henry C; Weber M
Pathol Biol (Paris); 1989 May; 37(5):346-9. PubMed ID: 2780092
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of pulmonary Mycobacterium kansasii infection].
Mizutani S
Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388
[TBL] [Abstract][Full Text] [Related]
15. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Kajitani H; Akaki T; Shishido S
Antimicrob Agents Chemother; 2000 Feb; 44(2):283-6. PubMed ID: 10639351
[TBL] [Abstract][Full Text] [Related]
16. [Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg-based Ogawa and agar-based Middlebrook 7H10 media].
Yamane N; Chilima BZ; Tosaka M; Okazawa Y; Tanno K
Kekkaku; 1996 Aug; 71(8):453-8. PubMed ID: 8831190
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
Tomioka H; Sato K; Akaki T; Kajitani H; Kawahara S; Sakatani M
Antimicrob Agents Chemother; 1999 Dec; 43(12):3001-4. PubMed ID: 10582897
[TBL] [Abstract][Full Text] [Related]
18. [View of development of fluoroquinolones].
Namba K
Kekkaku; 1999 Jan; 74(1):47-52. PubMed ID: 10067055
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin.
Vacher S; Pellegrin JL; Leblanc F; Fourche J; Maugein J
J Antimicrob Chemother; 1999 Nov; 44(5):647-52. PubMed ID: 10552981
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].
Sato K; Tomioka H
Kekkaku; 1999 Jan; 74(1):63-70. PubMed ID: 10067057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]